ArticleCureus2025
Impact of Trainee Involvement on Outcomes in Acute Cholangitis: A Propensity-Matched Study in U.S. Hospitals.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThis study analyzed the outcomes of acute cholangitis (AC) in teaching hospitals, comparing July-September (new trainees) to April-June (experienced trainees). The July trainee transition may increase errors and inefficiencies despite diligent staff efforts. Outcomes were evaluated to determine the impact of trainee experience on patient care during these critical educational periods.
methodThis study analyzed adult hospitalizations (age >18) with AC in U.S. teaching hospitals using the National Inpatient Sample (2016-2020). A retrospective multivariate analysis was conducted using SAS 9.4 to evaluate inpatient mortality, length of stay (LOS), total hospitalization cost (THC, adjusted to 2020 USD), critical care interventions (e.g., intubation, ICU admission, CVC placement), endoscopic retrograde cholangiopancreatography (ERCP) utilization (with/without intervention), and ERCP timing from admission.
resultsA total of 12,360 patients were included in this analysis. Of those, 6355 (~51.42%) were admitted during July-Sept and 6005 (~48.58%) were admitted during April-June across a five-year period (2016-2020) in the United States. The median age of the patients was 73 years (IQR: 61-83) and 72 years (IQR: 61-83) for the period of July-Sept and April-June, respectively. Primary outcomes showed no difference in terms of in-patient mortality between the two groups (3.49% vs. 2.95%, p=0.1061). THC was slightly higher in the April-June group ($15,492 vs. $14,553) than in the July-Sept group. There were significantly higher rates of ICU admissions (6.26% vs. 4.83%, p=0.0009) and intubation (5.09% vs. 3.75%, p=0.0006) for patients who were managed during the months of July-Sept compared to those managed in April-June. However, there was no difference between two groups requiring central venous catheter (CVC) line placement (1.88% vs. 1.79%, p=0.7245) and ERCP utilization (85.17% vs. 85.25%, p=0.8941). Analysis revealed that the majority of patients had ERCP between 24 and 48 hours of admission in both groups (51.09% vs. 50.03%), than within 24 hours (25.42% vs. 25.02%) and after 48 hours (23.48% vs. 24.85%). However, there was no significant difference in timing between the two groups.
conclusionAC has no significant difference in mortality, LOS, THC, ERCP utilization, or ERCP timing between the two groups. However, patients managed from July to September experienced higher rates of ICU admissions and intubations compared to those managed from April to June. This may indicate a lower threshold for critical interventions due to trainee inexperience, with higher life-sustaining intervention rates driven by heightened patient safety measures to prevent errors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.